Robert F. Murphy is Professor of Computational Biology Emeritus in the School of Computer Science at Carnegie Mellon University. He was the Ray and Stephanie Lane Professor of Computational Biology and Professor of Biological Sciences, Biomedical Engineering, and Machine Learning at Carnegie Mellon until his retirement in May 2021. He founded the Computational Biology Department in the School of Computer Science at Carnegie Mellon and served as its head from 2009 to 2020. He also cofounded, and served on the board of directors of, Quantitative Medicine, LLC, which was acquired by Predictive Oncology Inc. in July 2020. He has been an editor for the three main bioinformatics journals, a member of the National Advisory General Medical Sciences Council and the NIH Council of Councils, and a member of a number of external advisory boards. He is a Fellow of the IEEE and the American Institute of Medical and Biological Engineering. His interests and experience are in many aspects of machine learning, computational biology and biomedical research, especially in machine learning methods for biomedical image analysis and modeling and AI systems for driving experimental science.